Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-029620
Filing Date
2013-05-30
Accepted
2013-05-30 16:42:57
Documents
2
Period of Report
2013-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 59827
2 POA DOCUMENT poa.txt EX-24.4_475290 3248
  Complete submission text file 0001209191-13-029620.txt   64475
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address
GALAKATOS NICHOLAS (Reporting) CIK: 0001252522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35935 | Film No.: 13882271

Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Issuer) CIK: 0001269021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations